Status:
RECRUITING
Treating Major Depression With Yoga Mono-therapy
Lead Sponsor:
University of California, San Francisco
Conditions:
Depression Mild
Depression Moderate
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults...
Detailed Description
Consenting participants will be randomized equally to one of three in-person group interventions for 12 weeks: Standard yoga practice, Ayurvedic yoga practice, or educational attention-control modules...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- 18 years of age or older
- Able to give voluntary, informed consent
- English-speaking
- Diagnosis of clinical depression
- Exclusion criteria:
- Current use of antidepressant medication
- Current engagement in psychotherapy
- Current pregnancy
- Significant medical issues interfering with yoga practice
Exclusion
Key Trial Info
Start Date :
October 25 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT06091527
Start Date
October 25 2024
End Date
June 1 2026
Last Update
November 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zuckerberg San Francisco General Hospital
San Francisco, California, United States, 94110